foxo4 dri senolytic peptide human trials FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI | FOXO4/p53 Interaction Blocker
FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI Peptide (Proxofim) 10mg BiotechPeptides
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



